ResMed (RMD) Tops Q2 EPS by 10c
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $195.27 +1.76%
EPS Growth %: +13.3%
Financial Fact:
Income taxes (note 13): 16.82M
Today's EPS Names:
ORPB, ONEG, NDLS, More
EPS Growth %: +13.3%
Financial Fact:
Income taxes (note 13): 16.82M
Today's EPS Names:
ORPB, ONEG, NDLS, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q2 EPS of $1.88, $0.10 better than the analyst estimate of $1.78. Revenue for the quarter came in at $1.2 billion versus the consensus estimate of $1.15 billion.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- American Express down 2% in premarket trade after Q2 revenue miss offsets EPS beat
- HSBC starts SpaceX at Hold, sees execution risks tempering long-term AI ambitions
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
